-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RGgxcL+ZKSxEe3aMqxVVDYPwxXwyt5Kgk2eLGogdzVfaPNQL7fNujOiLcB8J5LYe IFkD3yShcRwgk2dJ5Cqprg== 0001104659-04-012529.txt : 20040505 0001104659-04-012529.hdr.sgml : 20040505 20040505063611 ACCESSION NUMBER: 0001104659-04-012529 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040505 ITEM INFORMATION: ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20040505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KINETIC CONCEPTS INC /TX/ CENTRAL INDEX KEY: 0000831967 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FURNITURE & FIXTURES [2590] IRS NUMBER: 741891727 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09913 FILM NUMBER: 04779459 BUSINESS ADDRESS: STREET 1: 8023 VANTAGE DR CITY: SAN ANTONIO STATE: TX ZIP: 78230 BUSINESS PHONE: 210.524.9000 MAIL ADDRESS: STREET 1: P0 B0X 659508 CITY: SAN ANTONIO STATE: TX ZIP: 78265-9508 8-K 1 a04-5339_18k.htm 8-K

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

FORM  8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 


 

Date of Report
May 5, 2004

 

Commission file number 001-09913

 

KINETIC CONCEPTS, INC.

(Exact name of registrant as specified in its charter)

 

Texas

 

74-1891727

(State of Incorporation)

 

(I.R.S. Employer Identification No.)

 

 

 

8023 Vantage Drive
San Antonio, Texas 78230
Telephone Number: (210) 524-9000

(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)

 

 



 

Item 7.  Financial Statements and Exhibits.

 

(c) Exhibit

 

99.1 Kinetic Concepts, Inc. press release dated May 5, 2004.

 

Item 12.  Results of Operations and Financial Condition.

 

The information in this Current Report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

Registrant is furnishing its press release dated May 5, 2004, which announces the Registrant’s financial results for the three months ended March 31, 2004.  The text of the press release is attached as Exhibit 99.1 hereto.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

KINETIC CONCEPTS, INC.

 

(REGISTRANT)

 

 

 

 

 

By:

/s/ Martin J. Landon

 

Date: May 5, 2004

Martin J. Landon

 

Vice President and Chief Financial Officer

 

2


EX-99.1 2 a04-5339_1ex99d1.htm EX-99.1

Exhibit 99.1

 

Contact  Martin J. Landon – Investors
KCI
(210) 255-6494

 

Elliot Sloane – Media
Sloane & Company
(212) 446-1860

 

 

KINETIC CONCEPTS REPORTS
 FIRST QUARTER 2004 FINANCIAL RESULTS

 

 

San Antonio, Texas, May 5, 2004 – Kinetic Concepts, Inc. (“KCI” or the “Company”) today reported first quarter 2004 net revenue of $224.8 million, an increase of 35% from the first quarter of 2003.  Excluding the effects of foreign currency exchange movements, net revenue for the first quarter increased 30% over the prior year.

 

On February 24, 2004, KCI began trading as a public company (NYSE:  KCI).  Including after-tax expenses of $18.0 million and in-kind preferred stock dividends of $65.6 million associated with KCI’s initial public offering (“IPO”), the Company reported a loss per diluted share, after dividends, of $1.19 for the first quarter compared to earnings per diluted share of $0.21 in the prior year.  Net earnings for the first quarter of 2004 were $5.5 million before preferred stock dividends.  After recognition of the preferred stock dividends, KCI reported a net loss available to common shareholders of $60.1 million.

 

Excluding expenses and preferred stock dividends associated with the IPO, net earnings for the first quarter of 2004 would have been $23.5 million, up 39% from net earnings of $16.9 million for the same period a year ago. Earnings per diluted share, excluding expenses and dividends associated with the IPO, would have been $0.34 in the first quarter of 2004 compared to $0.21 in 2003, a 62% improvement over the prior year.

 

A total of 20.7 million shares of KCI common stock were sold in the IPO, including 3.5 million newly-issued shares.  Upon the closing of the IPO, the Company accelerated recognition of in-kind preferred stock dividends and converted all outstanding shares of preferred stock into 19.2 million shares of common stock.  At March 31, 2004, KCI had 64.8 million shares of common stock outstanding.  Net IPO proceeds to KCI of approximately $74.9 million were used to pay down long-term debt.

 

“We are pleased with the performance of our business in the first quarter and with the response to our initial public offering,” said Dennert O. Ware, president and chief executive officer of KCI.   “We continue to execute on our strategic plan and we are delivering on both our short and long-term performance metrics.  Several factors contributed to our first quarter performance including strong demand for our V.A.C. systems, increased revenue in our surfaces business and our ongoing investment in sales and marketing — all of which led to improved operating margins.”

 

Revenue Recap – Q1 2004

 

Revenue for the first quarter of 2004 was $224.8 million, an increase of 35% from the prior-year period.  Domestic revenue for the period was $169.9 million, a 33% increase from the first quarter of 2003 due primarily to increased rental and sales volumes for V.A.C. wound healing devices and related disposables.  International revenue of $54.9 million increased 39% compared to the prior-year period as a result of increased V.A.C. demand, higher therapeutic surface revenue and favorable foreign currency exchange movements.  Excluding the effects of foreign currency exchange movements, international revenue increased 21% from the first quarter of the prior year.

 

V.A.C. revenue was $148.3 million for the first quarter of 2004, an increase of 51% from the prior-year period.  Domestic V.A.C. revenue was $121.6 million in the quarter, an increase of 48% compared to the prior year.  First quarter international V.A.C. revenue was $26.7 million, an increase of 69% from the prior-year period.  Excluding the effects of foreign currency exchange movements, international V.A.C. revenue for the period

 



 

increased 47% from the prior-year period.  The growth in V.A.C. was bolstered by increased physician and payer awareness of the benefits of V.A.C. therapy, and increased product adoption across wound types.

 

Surface revenue was $76.5 million for the first quarter of 2004, an increase of 11% from the prior-year period primarily due to higher surface product utility resulting from a severe winter flu season in the U.S., and growth in international markets.  International surface results also benefited from favorable currency exchange rate variances.  Domestic surface revenue for the first quarter of 2004 was approximately $48.4 million, an increase of 7% from the prior-year period.   International surface revenue for the first quarter was $28.2 million, an increase of 20% from a year ago. Excluding the effects of foreign currency exchange movements, international first quarter surface revenue increased 3% from the prior-year period.

 

Income Tax Rate

 

The effective tax rate for the first quarter of 2004 was 36% compared to 37.5% for the same period a year ago.  The income tax rate reduction is primarily attributable to our tax structure, which is designed to result in higher revenue in lower tax jurisdictions.

 

Liquidity

 

As of March 31, 2004, KCI had $568.3 million of total debt (long-term debt, capital lease obligations and liability associated with interest rate swaps) outstanding.  During the quarter, the Company redeemed $71.8 million of its 7 3/8% Senior Subordinated Notes due 2013, and paid an additional $50.0 million under the senior credit facility.  Total cash at March 31, 2004 was $93.2 million. Borrowing availability under the revolving credit facility at March 31, 2004 was $86.2 million.  Working capital changes during the period include a tax payment of $28.1 million related to receipt of the second and final installment of an anti-trust litigation settlement that we reached in 2002. In addition, the current income tax payable reflects tax benefits of $10.1 million associated with the IPO, which will be realized in the second quarter of 2004.

 

Outlook

 

The following guidance is based on current information and expectations as of May 5, 2004.  Because KCI only recently began trading its equity in the public markets, the Company is providing revenue and earnings guidance for both the second quarter and full year of 2004.

 

Q2 2004

 

Forecast

 

 

 

Revenue

 

$230 - $240 million

 

 

 

Net Earnings

 

$24 - $26 million

 

 

 

EPS

 

$0.34 - $0.36

 

 

 

Diluted Shares

 

70.5 - 71.5 million

 

 

 

 

 

 

 

 

 

 

 

 

 

Forecast

 

Full Year 2004

 

Forecast

 

(As Adjusted) (1)

 

Revenue

 

$940 - $970 million

 

$940 - $970 million

 

Net Earnings

 

$82 - $88 million

 

$100 - $106 million

 

EPS

 

$0.24 - $0.33

 

$1.42 - $1.48

 

Diluted Shares

 

67.5 - 68.5 million (2)

 

70.5 - 71.5 million

 

 


(1)

“As adjusted” forecast information excludes approximately $18.0 million of expenses and $65.6 million of preferred stock dividends associated with the initial public offering.

(2)

Due to their antidilutive effect, 2,990,000 dilutive potential common shares from preferred stock conversion have been excluded from the diluted weighted average shares calculation.

 

“We have a sound strategic plan that we are executing to promote our long-term success,” said Ware.  “Our key growth objectives are to further penetrate the wound closure market by driving V.A.C. adoption, to expand internationally and to continue innovating in all of our product areas.”

 



 

Non-GAAP Financial Information

 

Throughout this press release, we have presented income statement items on an adjusted basis to exclude the impact of all costs and the acceleration of preferred stock dividends incurred as a result of our initial public offering.  These adjusted non-GAAP financial measures do not replace the presentation of our GAAP financial results.  We have provided this supplemental non-GAAP information to demonstrate meaningful information regarding our results on a consistent and comparable basis for the periods presented.  Management uses this non-GAAP financial information for reviewing the operating results of its business segments and for analyzing potential future business trends in connection with its budget process.  In addition, we believe investors use the information to evaluate period-to-period results and to understand potential future operating results.  A reconciliation of our GAAP income statement for the periods presented to the non-GAAP financial information provided is included herein.

 

Earnings Release Conference Call

 

As previously announced, the Company has scheduled an earnings release conference call for 8:30 a.m. eastern daylight time today, Wednesday, May 5, 2004.  The dial-in numbers for this conference call are as follows:

 

Domestic Dial-in Number:

800-299-0148

International Dial-in Number:

+617-801-9711

Participant Code:

10686595

 

This call is being web cast by CCBN and can be accessed at the Kinetic Concepts, Inc. Web site at
http://www.kci1.com/investor/index.asp, and clicking on Web cast — Q1 2004 Kinetic Concepts Earnings Call.  The web cast is also being distributed over CCBN’s Investor Distribution Network to both institutional and individual investors.  Individual investors can listen to the call through CCBN’s individual investor center at www.fulldisclosure.com and institutional investors can access the call via CCBN’s password-protected event management site, StreetEvents (www.streetevents.com).  An archive of the Web cast will be available at http://www.kci1.com/investor/index.asp until May 5, 2005.

 

KCI’s business outlook as of today is expected to be available on KCI’s Investor Relations Web site.  It is currently expected that the full business outlook will not be updated until the release of KCI’s next quarterly earnings announcement, notwithstanding subsequent developments.  However, although KCI undertakes no duty to update its business outlook, KCI may update the full business outlook or any portion thereof at any time.

 

Kinetic Concepts, Inc. is a global medical technology company with leadership positions in advanced wound care and therapeutic surfaces.   We design, manufacture, market and service a wide range of proprietary products that can significantly improve clinical outcomes while reducing the overall cost of patient care by accelerating the healing process or preventing complications.  Our advanced wound care systems incorporate our proprietary Vacuum Assisted Closureâ, or V.A.C.â, technology, which has been clinically demonstrated to promote wound healing and reduce the cost of treating patients with serious wounds.  Our therapeutic surfaces, including specialty hospital beds, mattress replacement systems and overlays, are designed to address complications associated with immobility and obesity, such as pressure sores and pneumonia. We have an infrastructure designed to meet the specific needs of medical professionals and patients across all health care settings including acute care hospitals, extended care facilities and patients’ homes both in the United States and abroad.

 

This press release contains forward-looking statements including, among other things, management’s estimates of future performance, revenue and earnings, our management’s growth objectives and our management’s ability to produce consistent operating improvements.  The forward-looking statements contained herein are based on our current expectations and are subject to a number of risks and uncertainties which could cause us to fail to achieve our current financial projections and other expectations, such as a change in the demand for the V.A.C. resulting from increased competition, a change in payer reimbursement policies, our ability to protect our intellectual property rights and general economic conditions.  All information set forth in this release and its attachments is as of May 5, 2004.  We undertake no duty to update this information.  More information about potential factors that could affect our business and financial results is included in our Annual Report on form 10-K for the fiscal year ended December 31, 2003, including, among other sections, under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which is on file with the SEC and available at the SEC’s website at www.sec.gov.  Additional information will also be set forth in those sections in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2004, which will be filed with the SEC in the second quarter of 2004.

 



 

KINETIC CONCEPTS, INC. AND SUBSIDIARIES
Condensed Consolidated Statement of Earnings (1)
(in thousands, except per share data)

(unaudited)

 

 

 

Three months ended March 31,

 

 

 

 

 

 

2004

 

 

 

 

 

2004

 

IPO Related
Costs and Expenses

 

Excluding IPO
Related Costs
and Expenses

 

2003

 

%
Change

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

Rental

 

$

165,908

 

$

 

$

165,908

 

$

129,442

 

28.2

%

Sales

 

58,926

 

 

58,926

 

37,561

 

56.9

%

Total revenue

 

224,834

 

 

224,834

 

167,003

 

34.6

%

 

 

 

 

 

 

 

 

 

 

 

 

Rental expenses

 

105,406

 

 

105,406

 

79,379

 

32.8

%

Cost of goods sold

 

16,768

 

 

16,768

 

13,645

 

22.9

%

Gross profit

 

102,660

 

 

102,660

 

73,979

 

38.8

%

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

48,542

 

 

48,542

 

36,481

 

33.1

%

Research and development expenses

 

7,119

 

 

7,119

 

4,425

 

60.9

%

Initial public offering indirect expenses

 

19,534

 

(19,534

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating earnings

 

27,465

 

19,534

 

46,999

 

33,073

 

42.1

%

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

371

 

 

371

 

400

 

(7.3

)%

Interest expense

 

(18,844

)

8,634

 

(10,210

)

(8,178

)

(24.8

)%

Foreign currency gain (loss)

 

(464

)

 

(464

)

1,788

 

(126.0

)%

Earnings before income taxes

 

8,528

 

28,168

 

36,696

 

27,083

 

35.5

%

Income taxes

 

3,070

 

10,140

 

13,210

 

10,156

 

30.1

%

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings

 

$

5,458

 

$

18,028

 

$

23,486

 

$

16,927

 

38.7

%

Series A convertible preferred stock dividends

 

(65,604

)

65,604

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings (loss) available to common shareholders

 

$

(60,146

)

$

83,632

 

$

23,486

 

$

16,927

 

38.7

%

Net earnings (loss) per share available to common shareholders:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(1.19

)

 

 

$

0.47

 

$

0.24

 

95.8

%

Diluted

 

$

(1.19

)

 

 

$

0.34

 

$

0.21

 

61.9

%

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

50,332

 

 

 

50,332

 

70,995

 

 

 

Diluted

 

50,332

(2)

 

 

68,293

 

79,861

 

 

 

 


(1)

Throughout this press release, we have presented income statement items on an adjusted basis to exclude the impact of all costs and preferred stock dividends incurred as a result of our initial public offering.  These adjusted non-GAAP financial measures do not replace the presentation of our GAAP financial results.  We have provided this supplemental non-GAAP information to provide meaningful information regarding our results on a consistent and comparable basis for the periods presented.  Management uses this non-GAAP financial information for reviewing the operating results of its business segments and for analyzing potential future business trends in connection with its budget process.  In addition, we believe investors use the information to evaluate period-to-period results and to understand potential future operating results.  A reconciliation of our GAAP income statement for the periods presented to the non-GAAP financial information provided is included herein.

(2)

Due to their antidilutive effect, 5,934,824 dilutive potential common shares from stock options and 12,026,073 dilutive potential common shares from preferred stock conversion have been excluded from the diluted weighted average shares calculation for the three months ended March 31, 2004.

 



 

KINETIC CONCEPTS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

March 31,
2004

 

December 31,
2003

 

 

 

(unaudited)

 

 

 

Assets:

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

93,243

 

$

156,064

 

Accounts receivable, net

 

200,034

 

199,938

 

Inventories, net

 

30,102

 

32,253

 

Deferred income taxes

 

22,925

 

22,749

 

Prepaid expenses and other current assets

 

14,421

 

11,811

 

Total current assets

 

360,725

 

422,815

 

 

 

 

 

 

 

 

 

 

 

 

 

Net property, plant and equipment

 

155,085

 

145,208

 

Loan and preferred stock issuance costs, less accumulated amortization of $1,590 in 2004 and $1,014 in 2003

 

14,931

 

19,779

 

Goodwill

 

48,791

 

48,797

 

Other assets, less accumulated amortization of $8,359 in 2004 and $8,190 in 2003

 

28,741

 

28,497

 

 

 

$

608,273

 

$

665,096

 

 

 

 

 

 

 

Liabilities and Shareholders’ Deficit:

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

30,719

 

$

34,386

 

Accrued expenses

 

100,153

 

112,652

 

Current installments of long-term debt

 

4,308

 

4,800

 

Current installments of capital lease obligations

 

1,536

 

1,576

 

Derivative financial instruments

 

4,293

 

2,402

 

Income taxes payable

 

14,793

 

39,403

 

Total current liabilities

 

155,802

 

195,219

 

 

 

 

 

 

 

Long-term debt, net of current installments

 

556,842

 

678,100

 

Capital lease obligations, net of current installments

 

1,337

 

1,351

 

Deferred income taxes, net

 

26,191

 

26,566

 

Deferred gain, sale of headquarters facility

 

8,915

 

9,183

 

Other noncurrent liabilities

 

212

 

212

 

 

 

749,299

 

910,631

 

Series A convertible preferred stock, 264 issued and outstanding at December 31, 2003

 

 

261,719

 

 

 

 

 

 

 

Shareholders’ equity (deficit):

 

 

 

 

 

Common stock; authorized 225,000 at March 31, 2004 and 150,000 at December 31, 2003; issued and outstanding 64,814 at March 31, 2004 and 41,270 at December 31, 2003

 

65

 

41

 

Additional paid-in capital

 

429,501

 

1,157

 

Deferred compensation

 

226

 

185

 

Retained deficit

 

(579,101

)

(518,955

)

Accumulated other comprehensive income

 

8,283

 

10,318

 

Shareholders’ deficit

 

(141,026

)

(507,254

)

 

 

 

 

 

 

 

 

$

608,273

 

$

665,096

 

 



 

KINETIC CONCEPTS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

 

 

Three months ended March 31,

 

 

 

2004

 

2003

 

Cash flows from operating activities:

 

 

 

 

 

Net earnings

 

$

5,458

 

$

16,927

 

Adjustments to reconcile net earnings to net cash provided (used) by operating activities:

 

 

 

 

 

Depreciation

 

9,637

 

9,952

 

Amortization

 

4,087

 

713

 

Provision for uncollectible accounts receivable

 

3,177

 

1,749

 

Amortization of deferred gain on sale of headquarters facility

 

(268

)

(259

)

Writeoff of deferred loan fees

 

3,342

 

 

Non-cash amortization of stock award to directors

 

42

 

 

Change in assets and liabilities

 

 

 

 

 

Increase in accounts receivable, net

 

(3,313

)

(6,983

)

Decrease in other accounts receivable

 

 

175,000

 

Decrease in inventories

 

2,135

 

2,992

 

Increase in prepaid expenses and other current assets

 

(2,608

)

(3,541

)

Increase (decrease) in accounts payable

 

(3,671

)

1,455

 

Increase (decrease) in accrued expenses

 

(10,381

)

3,025

 

Increase (decrease) in income taxes payable

 

(24,611

)

71,606

 

Decrease in current deferred income taxes

 

(176

)

(66,838

)

Increase (decrease) in deferred income taxes, net

 

279

 

(677

)

Net cash provided (used) by operating activities

 

(16,871

)

205,121

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Additions to property, plant and equipment

 

(20,841

)

(17,678

)

Increase in inventory to be converted into equipment for short-term rental

 

(3,100

)

(200

)

Dispositions of property, plant and equipment

 

395

 

404

 

Increase in other assets

 

(408

)

(323

)

Net cash used by investing activities

 

(23,954

)

(17,797

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Repayment of notes payable, long term, capital lease and other obligations

 

(121,805

)

(105,787

)

Initial public offering of common stock:

 

 

 

 

 

Proceeds from issuance of common stock

 

105,000

 

 

Stock issuance costs

 

(10,604

)

 

Proceeds from exercise of stock options

 

5,443

 

663

 

Net cash used by financing activities

 

(21,966

)

(105,124

)

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

(30

)

506

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

(62,821

)

82,706

 

Cash and cash equivalents, beginning of period

 

156,064

 

54,485

 

Cash and cash equivalents, end of period

 

$

93,243

 

$

137,191

 

 

 

 

 

 

 

Cash paid during the three months for:

 

 

 

 

 

Interest (1)

 

$

12,794

 

$

2,730

 

Income taxes

 

$

3,915

 

$

5,508

 

Non-cash activity:

 

 

 

 

 

Non-cash consideration for exercise of stock options

 

$

2,136

 

$

 

 


(1)

2004 amount includes $5.3 million related to the IPO.

 



 

KINETIC CONCEPTS, INC AND SUBSIDIARIES

SUPPLEMENTAL REVENUE DATA

(unaudited)

(in thousands)

 

 

 

Three months ended March 31,

 

 

 

 

 

 

 

Variance

 

 

 

2004

 

2003

 

$

 

%

 

USA

 

 

 

 

 

 

 

 

 

V.A.C.

 

 

 

 

 

 

 

 

 

Rental

 

$89,907

 

$65,288

 

$24,619

 

37.7

%

Sales

 

31,682

 

17,092

 

14,590

 

85.4

 

Total V.A.C.

 

121,589

 

82,380

 

39,209

 

47.6

 

 

 

 

 

 

 

 

 

 

 

Therapeutic surfaces/other

 

 

 

 

 

 

 

 

 

Rental

 

39,801

 

37,862

 

1,939

 

5.1

 

Sales

 

8,551

 

7,386

 

1,165

 

15.8

 

Total therapeutic surfaces/other

 

48,352

 

45,248

 

3,104

 

6.9

 

 

 

 

 

 

 

 

 

 

 

Total USA rental

 

129,708

 

103,150

 

26,558

 

25.7

 

Total USA sales

 

40,233

 

24,478

 

15,755

 

64.4

 

 

 

 

 

 

 

 

 

 

 

Subtotal – USA

 

$169,941

 

$127,628

 

$42,313

 

33.2

%

 

 

 

 

 

 

 

 

 

 

International

 

 

 

 

 

 

 

 

 

V.A.C.

 

 

 

 

 

 

 

 

 

Rental

 

$13,374

 

$7,818

 

$5,556

 

71.1

%

Sales

 

13,347

 

8,006

 

5,341

 

66.7

 

Total V.A.C.

 

26,721

 

15,824

 

10,897

 

68.9

 

 

 

 

 

 

 

 

 

 

 

Therapeutic surfaces/other

 

 

 

 

 

 

 

 

 

Rental

 

22,826

 

18,474

 

4,352

 

23.6

 

Sales

 

5,346

 

5,077

 

269

 

5.3

 

Total therapeutic surfaces/other

 

28,172

 

23,551

 

4,621

 

19.6

 

 

 

 

 

 

 

 

 

 

 

Total International rental

 

36,200

 

26,292

 

9,908

 

37.7

 

Total International sales

 

18,693

 

13,083

 

5,610

 

42.9

 

 

 

 

 

 

 

 

 

 

 

Subtotal – International

 

$54,893

 

$39,375

 

$15,518

 

39.4

%

 

 

 

 

 

 

 

 

 

 

Total revenue

 

$224,834

 

$167,003

 

$57,831

 

34.6

%

 



 

KINETIC CONCEPTS, INC. AND SUBSIDIARIES

Reconciliation of EBITDA to Cash Flows from Operations (1)

(in thousands)

(unaudited)

 

 

 

Three months ended March 31,

 

 

 

2004

 

2003

 

Net earnings (2)

 

$5,458

 

$16,927

 

Income tax expense

 

3,070

 

10,156

 

Interest expense (3)

 

18,844

 

8,178

 

Depreciation

 

9,637

 

9,952

 

Amortization (4)

 

3,511

 

134

 

 

 

 

 

 

 

EBITDA (2)

 

40,520

 

45,347

 

 

 

 

 

 

 

Provision for uncollectible accounts receivable

 

3,177

 

1,749

 

Amortization of deferred gain on sale of headquarters facility

 

(268

)

(259

)

Write-off deferred loan fees

 

3,342

 

 

Non-cash amortization-stock award to directors

 

42

 

 

Amortization of loan issuance costs

 

576

 

579

 

Income tax expense

 

(3,070

)

(10,156

)

Interest expense (3)

 

(18,844

)

(8,178

)

Change in assets and liabilities

 

(42,346

)

176,039

 

 

 

 

 

 

 

Net cash provided (used) by operating activities

 

$(16,871

)

$205,121

 

 


(1)

We use earnings before interest, taxes, depreciation and amortization (“EBITDA”) as a measure of leverage capacity and debt service ability.  We consider EBITDA to be a key liquidity measure but it should not be considered as a measure of financial performance under GAAP or as an acceptable alternative to GAAP cash flows from operating activities, net income or operating income.  Management uses this non-GAAP financial information to measure liquidity and we believe investors use the information for the same purpose.  We have provided this supplemental non-GAAP information to demonstrate meaningful information regarding our liquidity on a consistent and comparable basis for the periods presented.  Our definition of EBITDA is not necessarily comparable to similarly titled measures reported by other companies and is not the same as that term is used under our new senior credit agreement.

(2)

2004 includes $18.0 million of expenses, net of income taxes, related to our IPO.

(3)

Amount for 2004 includes an aggregate of $8.6 million in expense including the redemption premium of $5.3 million incurred in connection with the redemption of $71.75 million of our 7 3/8% Senior Subordinated Notes due 2013 and $3.3 million of loan issuance costs that we wrote off related to the pay down of debt.

(4)

Net of amortization of loan issuance costs, which is included in interest expense.

 


-----END PRIVACY-ENHANCED MESSAGE-----